Healthcare
Caixa Capital Risc leads €700,000 series-C for Biótica
Backers include the management team alongside existing shareholders
Progressio, Idea Capital reap €130m in Italchimici trade sale
Private equity backers have reaped 3x money after one-year holding period
CapMan sells Samsa to IK's Attendo
IK-backed listed company provides exit for CapMan Life Science IV fund
Livonia makes 10x on Qvalitas sale to BaltCap
Baltic GP earns 44% IRR over seven years on exit of final legacy portfolio asset
EQT in €830m Atos Medical exit to PAI
PAI Partners becomes the third private equity owner of Atos, following EQT and Nordic Capital
Sofimac et al. in €8m Ixaltis series-A
Company will use the fresh capital to develop its product pipeline and finance clinical trials
CapMan exits Esperi Care to ICG
Exit ends the six-year ownership of the care provider by CapManтs Buyout division
Ardian-backed Laboratoires Anios expands with Inibsa Hospital
Transaction marks the fourth bolt-on since Ardian invested in the company in 2013
IK in €300-350m deal to acquire Marle from Carlyle
IK is acquiring Marle through its buyout fund IK VII, closed on €1.4bn in October 2013
Albion Ventures et al. sell Haemostatix to Ergomed
Ergomed pays an initial consideration of ТЃ8m, with an extra contingent of ТЃ20m
VR Equitypartner invests in Schwa-medico
GP aims to support the business by continuing its buy-and-build strategy
Tensive raises €500,000 from Invitalia and Unicredit
State-backed VC firm Invitalia tapped its Italia Venture I fund for investment
Nazca reaps 2x on IMOncology exit
Deal marks the second divestment for the Nazca III fund, which now holds seven portfolio companies
Deal in Focus: Astorg sells Ethypharm after nine-year holding
Resisting regular suitors, the GP's nine-year tenure of the pharmaceutical company allowed it to fully implement a long-term acquisitive strategy
Polaris buys Akademikliniken from Valedo
Danish GP makes inaugural Swedish acquisition for 2015-vintage fourth fund
LSP and Versant back Nouscom's €12m series-A
Founders collaborated on an earlier venture, Okairos, which was exited to GlaxoSmithKline
Cinven's Synlab completes €190m refinancing
Laboratory analysis company will repay capital drawn from its revolving credit facility
Amadeus leads series-A for Inotec
Existing backers Cambridge Capital Group and Cambridge University did not participate in the round
Endeavour et al. lead $25m series-D for Endostim
Endeavour Vision led the funding round alongside Gimv and Wellington Partners
Keensight merges Tecres and Aap Biomaterials
As part of the deal, French GP bought Aap for €36.6m and invested in the new holding company
Principia buys 49% stake in Rigenerand for €8.7m
Deal marks the fourth transaction for the Principia III-Health venture capital vehicle
PAI in €725m deal to acquire Ethypharm from Astorg
Deal comes nine years after Astorg acquired a 60% stake in the company via the Astorg IV fund
Apposite invests up to £12m in Medical Imaging Partnership
Radiology company will undertake a recruitment drive and expand accross the UK
Clessidra, Mandarin et al. sell Euticals to Amri for $358m
Deal sees the GP syndicate acquire a 19.75% stake in US-listed buyer Amri